Citalopram No Better Than Placebo Treatment for Children with Autism Spectrum Disorders – 1
Narrator: This is NIH Health Matters. A recent study has found that citalopram, a medication commonly prescribed to children with autism spectrum disorders, was no more effective than placebo treatment for these children.
Dr. King: We proposed a study to look at whether the common usage citalopram would be effective in reducing repetitive behaviors that are so common in children with autism.
Narrator: Thatís Dr. Bryan King of the University of Washington and Seattle Childrenís Hospital. He says the study findings do not support using citalopram to treat repetitive behaviors in children with ASD. For more details on this study, visit www.nih.gov. Health Matters is produced by the National Institutes of Health, part of the US Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.